Viewing Study NCT00004159


Ignite Creation Date: 2025-12-24 @ 2:58 PM
Ignite Modification Date: 2026-01-24 @ 11:37 PM
Study NCT ID: NCT00004159
Status: TERMINATED
Last Update Posted: 2013-11-20
First Post: 1999-12-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor
Sponsor: University of Alabama at Birmingham
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CDR0000067399
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View